Unecritinib (TQ-B3101) is a selective tyrosine kinase receptor inhibitor ( prodrug of crizotinib). The hydrolysis of TQ-B3101 was mainly catalyzed by carboxylesterase 2 (CES2), followed by CES1
Type : Not A\/B H target, Pro-Drug, Drug, Piperidine, Pyrazole, Pyridine
Chemical_Nomenclature : N-[3-[(1R)-1-(2,6-dichloro-3-fluorophenyl)ethoxy]-5-(1-piperidin-4-ylpyrazol-4-yl)pyridin-2-yl]acetamide
Canonical SMILES : C[C@H](C1=C(C=CC(=C1Cl)F)Cl)OC2=C(N=CC(=C2)C3=CN(N=C3)C4CCNCC4)NC(=O)C
InChI : InChI=1S\/C23H24Cl2FN5O2\/c1-13(21-18(24)3-4-19(26)22(21)25)33-20-9-15(10-28-23(20)30-14(2)32)16-11-29-31(12-16)17-5-7-27-8-6-17\/h3-4,9-13,17,27H,5-8H2,1-2H3,(H,28,30,32)\/t13-\/m1\/s1
InChIKey : HBWSXXBJOQKNBL-CYBMUJFWSA-N
Other name(s) : 4T3Z98RR86 || UNII-4T3Z98RR86 || TQ-B3101 || Acetamide, N-(3-((1R)-1-(2,6-dichloro-3-fluorophenyl)ethoxy)-5-(1-(4-piperidinyl)-1H-pyrazol-4-yl)-2-pyridinyl)- || N-(3-((1R)-1-(2,6-Dichloro-3-fluorophenyl)ethoxy)-5-(1- (piperidin-4-yl)-1H-pyrazol-4-yl)pyridin-2-yl)acetamide\; ... || SCHEMBL14812649 || HY-147413
MW : 492.4
Formula : C23H24Cl2FN5O2
CAS_number : 1418026-92-2
PubChem : 71506874
UniChem : HBWSXXBJOQKNBL-CYBMUJFWSA-N
Structures : No structure
Families : Carb_B_Chordata
Title : Simultaneous determination of unecritinib (TQ-B3101) and its active metabolite crizotinib in rat plasma by LC-MS\/MS:An application to pharmacokinetic studies - Wang_2024_J.Pharm.Biomed.Anal_246_116199 |
Author(s) : Wang H , Chen H , Cui X , Zhang Y , Zhou J , Chen X |
Ref : J Pharm Biomed Anal , 246 :116199 , 2024 |
Abstract : |
PubMedSearch : Wang_2024_J.Pharm.Biomed.Anal_246_116199 |
PubMedID: 38744200 |